-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Emergent BioSolutions Inc. quarterly/annual Depreciation history and growth rate from Q1 2021 to Q2 2024.
- Emergent BioSolutions Inc. Depreciation for the quarter ending June 30, 2024 was $12.2M, a 27.4% decline year-over-year.
- Emergent BioSolutions Inc. Depreciation for the twelve months ending June 30, 2024 was $49M, a 32.6% decline year-over-year.
- Emergent BioSolutions Inc. annual Depreciation for 2023 was $59.5M, a 28.7% decline from 2022.
- Emergent BioSolutions Inc. annual Depreciation for 2022 was $83.4M, a 34.1% increase from 2021.
- Emergent BioSolutions Inc. annual Depreciation for 2021 was $62.2M, a 24.2% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)